Single Gene Disorders

A single gene disorder is a genetic condition caused by mutations or changes in one specific gene within our DNA. These disorders, also known as monogenic disorders, follow predictable inheritance patterns and can be passed from parents to children. Unlike chromosomal disorders which affect entire chromosomes, single gene disorders result from defects in individual genes that provide instructions for making proteins.

Examples of common single gene disorders include cystic fibrosis, sickle cell disease, Huntington’s disease, and thalassaemia. Over 10,000 different single gene disorders have been identified, affecting various body systems and causing a wide range of symptoms and severity levels.

Single gene disorders follow three main inheritance patterns: autosomal dominant, autosomal recessive, and X-linked. In autosomal dominant conditions, only one copy of the mutated gene is needed to cause the disorder, giving a 50% chance of passing it to each child. Autosomal recessive disorders require two copies of the mutated gene, occurring when both parents are carriers with a 25% recurrence risk.

X-linked disorders are carried on the X chromosome and primarily affect males, who have only one X chromosome. Females can be carriers and may pass the condition to their sons with a 50% chance for each pregnancy.

Yes, many single gene disorders can be detected during pregnancy through various screening and diagnostic methods. Carrier screening before or during pregnancy can identify parents at risk of having affected children. When both partners are carriers for the same recessive condition, diagnostic testing such as chorionic villus sampling or amniocentesis can confirm whether the fetus is affected.

Screening technologies, including certain NIPT options, are expanding to include some single gene disorders from as early as 9-10 weeks gestation. Additionally, detailed ultrasound scanning from 10 weeks can detect structural abnormalities associated with certain genetic conditions, prompting further genetic evaluation.

Carrier screening identifies individuals who carry one copy of a gene mutation for recessive genetic disorders without showing symptoms themselves. This testing is particularly important for couples planning pregnancy, as it reveals the risk of having children with genetic conditions. Modern carrier screening panels can test for hundreds of genes simultaneously using a simple blood sample.

Carrier screening is recommended for all couples, regardless of family history, as many people are unaware they carry genetic mutations. Comprehensive carrier screening allows couples to make informed reproductive decisions and plan appropriate prenatal care when needed.

Treatment options for single gene disorders vary significantly depending on the specific condition and affected body systems. Some disorders have effective treatments that can prevent or reduce symptoms, particularly when diagnosed early through newborn screening. Examples include dietary modifications for phenylketonuria (PKU) and enzyme replacement therapy for certain metabolic disorders.

Other conditions may have supportive treatments that manage symptoms and improve quality of life, whilst some currently have limited treatment options. Gene therapy and precision medicine are rapidly advancing fields that offer hope for treating previously incurable genetic conditions.

If your baby is diagnosed with a single gene disorder, a multidisciplinary team of specialists can work together to provide comprehensive care and support. The specific approach depends on the condition, but typically includes genetic counselling, specialist medical care, and family support services. Early intervention and appropriate treatment can significantly improve outcomes for many genetic conditions.

Healthcare teams can provide detailed information about the condition, discuss treatment options, and connect families with relevant support groups and resources. Many families find that genetic counselling helps them understand the condition and plan for future pregnancies when appropriate.

Yes, certain single gene disorders can contribute to pregnancy loss and recurrent miscarriage. Genetic abnormalities in the developing embryo or fetus may result in developmental problems that are incompatible with survival. Some single gene mutations affect essential cellular processes or organ development, leading to early pregnancy loss.

If recurrent pregnancy loss has occurred, genetic evaluation may be recommended to investigate possible underlying genetic causes. This assessment can help identify genetic factors and inform future pregnancy planning and management.

Genetic testing for single gene disorders is generally highly accurate, with accuracy varying by the specific condition being tested and the type of genetic change involved. Genetic testing generally detects known pathogenic variants reliably, but some genetic variations may be more difficult to detect than others.

It’s important to understand that genetic testing typically looks for known mutations associated with specific conditions. Very rare or previously unknown genetic changes might not be detected by standard testing panels, which is why genetic counselling is essential to discuss the limitations and implications of testing.

Yes, genetic testing can be valuable even without a family history of genetic conditions. Many people are unaware carriers of recessive genetic mutations because carriers typically don’t show symptoms. Additionally, some genetic conditions result from new mutations that weren’t inherited from parents.

Modern carrier screening panels can identify hundreds of genes, many of which are common enough to warrant screening regardless of family history. This approach allows couples to make informed decisions about family planning and prenatal care.

Screening tests estimate the probability or risk that a condition might be present, whilst diagnostic tests provide definitive confirmation of whether a condition is present. Screening tests, such as carrier screening or certain NIPT options, help identify pregnancies that may be at increased risk and warrant further evaluation.

Diagnostic tests, including chorionic villus sampling (CVS) and amniocentesis, directly analyse fetal genetic material to confirm or rule out specific genetic conditions. These tests carry a small risk of complications but provide definitive answers when needed for important medical decisions.

Some single gene disorders can directly impact fertility and reproductive function. Conditions such as cystic fibrosis can affect fertility in both men and women due to effects on reproductive organs. Other genetic conditions may affect hormone production, ovulation, or sperm production, leading to fertility challenges.

If there is a known genetic condition or family history affecting fertility, specialist reproductive genetic counselling can help assess available options. Modern assisted reproductive technologies, combined with genetic testing, can help couples achieve pregnancy whilst minimising genetic risks to their children.

Comprehensive support is available for families affected by single gene disorders, including medical specialists, genetic counsellors, and patient support organisations. Many conditions have dedicated charities and support groups that provide information, resources, and connections with other affected families.

Healthcare teams typically include geneticists, specialist nurses, and other professionals who can provide ongoing care and support. Genetic counselling services can offer continued support for family planning decisions and help families understand the medical and practical implications of genetic conditions.

Whilst single gene disorders are caused by inherited genetic mutations, environmental and lifestyle factors can sometimes influence the severity of symptoms or age of onset. For some conditions, dietary modifications, medication adherence, and lifestyle choices can significantly impact disease progression and quality of life.

Additionally, certain environmental exposures during pregnancy may interact with genetic predispositions to influence fetal development. Preconception counselling can help identify modifiable risk factors and optimise health before pregnancy when genetic conditions are present in the family.

Pharmacogenomics is the study of how genetic variations affect individual responses to medications. People with certain single gene disorders may metabolise medications differently, requiring personalised dosing or alternative treatments. Understanding genetic factors can help healthcare providers prescribe the most effective and safest medications.

This personalised approach to medicine is particularly important for treating genetic conditions, where targeted therapies may be more effective based on the specific genetic mutation involved. Genetic testing can inform treatment decisions and help optimise therapeutic outcomes.

Genetic mutations that cause single gene disorders can occur through various mechanisms, including point mutations, insertions, deletions, or duplications within the gene sequence. These changes can affect protein production by altering the genetic instructions, resulting in proteins that don’t function properly or aren’t produced at all.

The impact of a genetic mutation depends on its location within the gene and the role of the affected protein in normal cellular function. Some mutations completely eliminate protein function, whilst others may reduce activity or alter protein characteristics, leading to varying degrees of clinical severity.

Genetic counselling is recommended when there is a personal or family history of genetic conditions, abnormal screening results, or concerns about genetic risks. Couples planning pregnancy should consider counselling to discuss carrier screening options and understand their reproductive risks.

Additional situations warranting genetic counselling include recurrent pregnancy loss, infertility with suspected genetic causes, or when prenatal screening suggests increased genetic risk. Comprehensive genetic counselling can provide personalised risk assessment and guidance for informed decision-making about testing and reproductive options.

This page was created using information from the following trusted medical sources:

• Genetic abnormalities and pregnancy loss – PMC
• Maternal Genetic Disorders in Pregnancy – PMC
• Genetic Disorders and Pregnancy | ACOG
• Noninvasive prenatal diagnosis for single gene disorders – PubMed
• Prenatal Genetics Referral Guidelines | East Genomics
• National genomic test directory Testing criteria for rare and
• v1.0, release date: 21/05/2021 1 Clinicians Guide to the
• Genetic conditions Archives – Genomics Education Programme
• Genetic Conditions | Barnsley Hospital NHS Foundation Trust
• Single-Gene Disorders – Understanding Genetics – NCBI Bookshelf